Tridion Support | Component and Template Instructions | External Applications | Clinical Trials Listing | Details

GABA-glutamate Interactions and Psychosis

Conditions

Cognitive Dysfunction

What is the purpose of this trial?

This study investigates the interactions between NMDA (N-Methyl-D-aspartic acid) antagonism and GABA (gamma-aminobutyric acid) system as it relates to cognitive function assessed by ERPs (event-related potentials) in healthy volunteers.


Participation Guidelines

Age:
21 Years - 45 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.

Sponsor:
National Alliance for Research on Schizophrenia and Depression
Yale University
Dates:
January 2007
Last Updated:
May 17, 2012
Study HIC#:
0508000517

Clinicaltrials.gov ID: NCT00611572